阿昔洛韦和阿昔洛韦-氯倍他索纳米纤维乳膏与乳膏制剂治疗复发性唇疱疹的疗效比较。
Therapeutic effects of acyclovir and acyclovir-clobetasol nanofibers vs. cream formulation for recurrent herpes labialis.
机构信息
Pharmaceutical Research Center, Department of Pharmaceutics, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Dental Research Center, Department of Diagnosis of Oral and Dental Diseases, Faculty of Dentistry, Isfahan University of Medical Sciences, Isfahan, Iran.
出版信息
BMC Oral Health. 2024 Nov 6;24(1):1348. doi: 10.1186/s12903-024-04948-6.
OBJECTIVES
This study aims to compare the therapeutic effects of acyclovir nanofiber and acyclovir-clobetasol nanofiber formulations with their non-nano formulations (cream formulation) on recurrent labial herpes.
MATERIALS AND METHODS
Eighty patients with labial herpes lesions were divided into four groups, each receiving one of the following treatments: acyclovir-clobetasol nano patch, acyclovir-clobetasol cream, acyclovir nano patch, or acyclovir cream. Pain levels and recovery times were assessed. The Wilcoxon test compared pain levels, while the log-rank test compared healing and scabbing times.
RESULTS
Acyclovir-clobetasol nanofiber and cream, along with acyclovir nanofiber, significantly reduced symptoms compared to the acyclovir cream. The recovery and scabbing times were shorter in patients who received acyclovir-clobetasol formulations compared to those receiving acyclovir alone.
CONCLUSION
Acyclovir-clobetasol combinations accelerated recovery times compared to acyclovir alone. Additionally, nanofiber formulations demonstrated enhanced healing efficacy over cream formulations.
TRIAL REGISTRATION
This trial was retrospectively registered by Iranian Registry of Clinical Trials (IRCT) at 14/11/2023.
TRIAL REGISTRATION NUMBER
IRCT20230926059521N1.
目的
本研究旨在比较阿昔洛韦纳米纤维和阿昔洛韦-卤倍他索纳米纤维制剂与其非纳米制剂（乳膏制剂）在复发性唇疱疹治疗中的疗效。
材料和方法
将 80 例唇疱疹病变患者分为四组，分别接受以下治疗之一：阿昔洛韦-卤倍他索纳米贴剂、阿昔洛韦-卤倍他索乳膏、阿昔洛韦纳米贴剂或阿昔洛韦乳膏。评估疼痛水平和恢复时间。Wilcoxon 检验比较疼痛水平，对数秩检验比较愈合和结痂时间。
结果
与阿昔洛韦乳膏相比，阿昔洛韦-卤倍他索纳米纤维和乳膏以及阿昔洛韦纳米纤维均显著减轻了症状。与单独使用阿昔洛韦相比，接受阿昔洛韦-卤倍他索制剂的患者恢复和结痂时间更短。
结论
与单独使用阿昔洛韦相比，阿昔洛韦-卤倍他索联合用药加速了恢复时间。此外，纳米纤维制剂的愈合效果优于乳膏制剂。
试验注册
该试验由伊朗临床试验注册中心（IRCT）于 2023 年 11 月 14 日进行了回顾性注册。
注册号
IRCT20230926059521N1。
Zotero 插件